Jennifer Doudna

Research

CRISPR pioneer looks to tech's past, future in new review

Nobel Laureate Jennifer Doudna, Ph.D., predicts a bright future for the tech, complicated by a need for better delivery and high manufacturing costs.
Helen Floersh Jan 24, 2023 10:35am

Biogen takes another dip into Scribe gene therapy collab

May 2, 2022 3:03pm

CRISPR patent dispute not over yet as universities appeal

Apr 4, 2022 5:55pm

Bayer bolsters gene therapy ambition with Mammoth CRISPR deal

Jan 10, 2022 2:30am

Excision's HIV CRISPR therapy cleared for human studies by FDA

Sep 17, 2021 10:10am

Mammoth nets $195M to supercharge CRISPR diagnostics, medicines

Sep 9, 2021 9:00am